HIS
IOVA icon

Harvest Investment Services’s Iovance Biotherapeutics IOVA Stock Holding History

Harvest Investment Services’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-124,943
Closed -$880K – 167
2023
Q2 		$880K Buy
+124,943
New +$894K 0.5% 63

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harvest Investment Services's IOVA Position: Q3 2023 in Review

Harvest Investment Services sold out of Iovance Biotherapeutics (IOVA) in Q3 2023, closing a stake of 124,943 shares — an estimated $880K sold.

Harvest Investment Services first reported a position in IOVA in Q2 2023 and held it in 1 quarter. The position peaked at $880K in Q2 2023. 227 funds tracked by Wall St. Rank hold IOVA as of Q3 2023.

  • Harvest Investment Services reported no remaining Iovance Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Harvest Investment Services sold 124,943 Iovance Biotherapeutics shares in Q3 2023, an estimated $880K.
  • Harvest Investment Services first reported a position in Iovance Biotherapeutics in Q2 2023 and held it in 1 quarter.
  • Harvest Investment Services's Iovance Biotherapeutics position peaked at $880K in Q2 2023.
  • 227 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2023.

Based on Harvest Investment Services's 13F filing for Q3 2023, filed 14 Nov 2023.